Please login to the form below

Not currently logged in
Email:
Password:

intepirdine

This page shows the latest intepirdine news and features for those working in and with pharma, biotech and healthcare.

Axovant drops last ‘legacy’ drug to focus on gene therapies

Axovant drops last ‘legacy’ drug to focus on gene therapies

The decision to scrap nelotanserin comes after Axovant’s Alzheimer’s disease candidate intepirdine joined the chorus of failed drug candidates in that indication, and draws a line under the

Latest news

More from news
Approximately 2 fully matching, plus 5 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides powerful, insight-driven, scientific and medical communication services to the pharmaceutical industry across the globe, with...

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Infographics